Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia
Abstract Despite therapeutic advances, mortality of Acute Myeloid Leukemia (AML) is still high. Currently, the determination of prognosis which guides treatment decisions mainly relies on genetic markers. Besides molecular mechanisms, the ability of malignant cells to evade immune surveillance influ...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2022-09-01
|
| coleção: | Scientific Reports |
| Acesso em linha: | https://doi.org/10.1038/s41598-022-19972-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|